Neuroprotection in glaucoma
2011

Neuroprotection in Glaucoma

publication Evidence: moderate

Author Information

Author(s): Vasudevan Sushil K, Gupta Viney, Crowston Jonathan G

Primary Institution: Centre for Eye Research Australia, University of Melbourne

Hypothesis

Neuroprotection should be beneficial irrespective of the pathophysiology of glaucoma.

Conclusion

Neuroprotection has promise for preventing retinal ganglion cell death in glaucoma, independent of intraocular pressure.

Supporting Evidence

  • Glaucoma is a neurodegenerative disease characterized by loss of retinal ganglion cells.
  • Lowering intraocular pressure does not prevent progression in all patients.
  • Neuroprotection aims to protect neurons from degeneration and apoptosis.

Takeaway

Glaucoma is a disease that damages the eye's nerve cells, and protecting these cells can help prevent vision loss, even if the pressure in the eye is normal.

Methodology

This review article synthesizes current understanding of glaucoma's pathophysiology and explores pharmacological approaches for neuroprotection.

Limitations

Many studies on neuroprotective agents have had low success rates in transitioning from laboratory to human trials.

Digital Object Identifier (DOI)

10.4103/0301-4738.73700

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication